Dr. Kassis as Harvards’ Director of Experimental Radionuclide Therapy

Dr. Kassis as Harvards’ Director of Experimental Radionuclide Therapy

01 Jan 2022

It is every arab person, and especially Syrians’ pride to have Amin Kassis, the son of Iskandar Kassis, a renowned Syrian physician, and the TAKREEM winner for Scientific and Technological Achievement winner – 2013; named as Harvards’ Director of Experimental Radionuclide Therapy. It is worthy that in March 2021 his patent entitled: "Methods of detecting signatures of disease or conditions in bodily fluids” was registered in America . This is a great achievement and something to really be proud of, as it inspires more and more hope for our region.